In order to analyse their role as a specific marker of vascular damage and their value in monitoring disease activity the plasma concentrations of von Willebrand factor antigen (vWFAg) and the ristocetin cofactor (RiCoF) activities were determined in 43 children with vasculitis and 20 controls. These patients were subdivided into three groups according to diagnosis: Henoch-Schonlein purpura (n= 18), polyarteritis nodosa (n= 16), and systemic lupus erythematosus (n=9). High concentrations ofvWFAg and activities of RiCoF were found in all the patient groups. vWFAg and RiCoF returned to normal as the patients became symptom free and remained above normal in those with continuing symptoms. The amount of vWFAg did not correlate with the acute phase reactants. vWFAg acted as a specific marker of vascular damage and was useful for the monitoring of disease activity both in small vessel vasculitis and systemic necrotising arteritis.
Vasculitic syndromes are inflammatory diseases of blood vessels that usually result in destruction of vessel walls and produce vascular occlusion.' Vasculitis may arise de novo as a primary disorder of blood vessels (for example polyarteritis nodosa) or it may occur as a secondary feature of a diverse group of systemic diseases (for example systemic lupus erythematosus). As reports.'0 The correlation of vWFAg concentrations with the size of the involved blood vessel is also disputed.9 11 In this study we determined the plasma vWFAg concentrations and the ristocetin induced platelet agglutination (ristocetin cofactor RiCoF), which reflects the function of the von Willebrand factor,'2 in children with vasculitis. We compared the concentrations of vWFAg with the results of the commonly used acute phase reactants. We repeated the tests in remission and in those cases with ongoing clinical symptoms in order to correlate the results with the clinical findings.
Patients and methods

PATIENTS
The patient population consisted of 43 children and young adults aged 3 to 18 years who were followed up in the paediatric nephrology/rheumatology clinics. There were 18 males and 25 females (M:F=0-7:1). All the patients were studied prospectively; blood was obtained from the patients at the time a diagnosis of vasculitis was made and during the follow up perio0. The figure) . High concentrations com-1:1 to 1:160. Aliquots pared with the control group were also found vas made to react with in all three subgroups (see table 1). vWFAg cially available reagent concentrations were normal in two patients lining stabilised human with Henoch-Schonlein purpura restricted to nd stabilisers on a glass the skin who had less severe clinical symptoms. Lilution step in which a In the group with polyarteritis nodosa two n was observed in patients with myalgia and arthralgia as the saline solution control dominating symptoms had normal results. dicating the RiCoF conIn 23 patients tests were repeated when the multiplied by the given patients had no symptoms and the vWFAg ,throcyte sedimentation concentrations were found to be significantly decreased compared with the previous concentrations (p<001; with the erythrocyte sedimentation vWFAg concentrations and thus identify those concentrations of fibrinogen or cases who require invasive investigations. )mplexes in the three groups of Bowyer et al, comparing two children with th vasculitis (table 3) . The con-systemic polyarteritis nodosa with two children f C reactive protein was related to with cutaneous polyarteritis nodosa, found concentrations in the group with raised vWFAg concentrations only in the nodosa only (r=0-60).
group with systemic disease and proposed that and RiCoF were well correlated these results confirmed the former study isease activity, with higher than despite the limited number of cases.1 OThus far lts obtained when the patients had a relevant study has not been published to ptoms and normal values when the confirm this. We found no difference between lad subsided (p<0001). No such our patients with Henoch-Schonlein purpura was found with the erythrocyte and polyarteritis nodosa where the vWFAg and on rate or the C reactive protein or RiCoF values were concerned. We think that a oncentrations. discrimination between small vessel vasculitis and systemic necrotising arteritis cannot be made by vWFAg and these cases require more invasive investigations. synthesised by and present in When we repeated the tests in the follow up cells and it is released from the period we found that vWFAg and RiCoF ide storage bodies induced by decreased to normal in 21 patients among the imuli.18 High plasma concentra-23 in remission (tables 1 and 2). In eight een reported in a variety of diseases patients with ongoing clinical findings followed )od vessels. In our study we have up for a period of eight months, vWFAg and vWFAg and RiCoF values are RiCoF values remained above normal in all the plasma of children with vasculitis patients. These were two patients with ues were equally high in all three Henoch-Schonlein purpura admitted with a groups. As these three groups second attack with findings restricted to the ;mall vessel vasculitis, systemic skin, four patients with polyarteritis nodosa arteritis and secondary vascular with ongoing skin lesions, myalgia and t in systemic disease, we consider arthralgia, and two patients with systemic isma concentrations ofvWFAg and lupus erythematosus followed up for arthritis, ities reflect vascular damage of any skin lesions, and convulsions.
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